Heart failure & cardiomyopathies

Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications

Circ Heart FailPublished retrospective observational study

Authors' conclusion

Our findings affirm previous evidence that myocardial inflammation is present in approximately one-third of all patients with ATTR-CA. Moreover, we provide first data indicating that myocardial inflammation may be associated with a higher risk of death and heart failure hospitalizations in ATTR-CA.

Study context

Population
Patients with ATTR-CA diagnosed by endomyocardial biopsypatients with ATTR-CA (100 wild type, 3 variant) · wild type 100 · variant 3
Participants
103 patients
Exposure
Patients with ATTR-CA with and without myocardial inflammation
  • With myocardial inflammationn = 33
  • Without myocardial inflammationn = 70reference
Outcome
All-cause death and a composite end point of all-cause death or heart failure hospitalization
Follow-up
Median 18.2 (8.0-31.1) months

Main finding

As reported in the abstract

with myocardial inflammation vs without myocardial inflammationAdjusted hazard ratio (95% CI)P value
All-cause death; adjusted for age and sex
4.72(1.33–16.71)
P = 0.016
Composite end point; adjusted for age and sex
2.30(1.04–5.11)
P = 0.041
Overall survival significantly impaired with myocardial inflammation
P = 0.017
Composite end point-free survival significantly impaired with myocardial inflammation
P = 0.014

Observational data: associations, not effects.

Further findings

Prevalence of myocardial inflammation

Myocardial inflammation prevalent in patients with ATTR-CA
32% (n=33/103)
Among evaluable patients with myocardial inflammation, elevated CD68-positive macrophage counts
96% (n=26/27)
Among evaluable patients with myocardial inflammation, elevated CD3-positive T-cell counts
31% (n=9/29)

Original publication

Myocardial Inflammation in Cardiac Transthyretin Amyloidosis: Prevalence and Potential Prognostic Implications. Circ Heart Fail. Published 27 January 2025. doi:10.1161/circheartfailure.124.012146

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.